BARTOLOMEI, MIRCO
 Distribuzione geografica
Continente #
NA - Nord America 2.656
AS - Asia 1.929
EU - Europa 967
SA - Sud America 357
AF - Africa 59
OC - Oceania 11
Totale 5.979
Nazione #
US - Stati Uniti d'America 2.557
SG - Singapore 794
CN - Cina 378
BR - Brasile 282
VN - Vietnam 238
IT - Italia 233
PL - Polonia 160
HK - Hong Kong 138
DE - Germania 127
GB - Regno Unito 96
JP - Giappone 59
CA - Canada 53
IN - India 52
FR - Francia 49
TR - Turchia 48
UA - Ucraina 42
SE - Svezia 41
RU - Federazione Russa 39
ID - Indonesia 35
MX - Messico 35
FI - Finlandia 32
BD - Bangladesh 25
IR - Iran 24
ES - Italia 23
NL - Olanda 23
ZA - Sudafrica 23
AR - Argentina 22
AT - Austria 21
BE - Belgio 21
KR - Corea 19
EC - Ecuador 15
IQ - Iraq 15
LT - Lituania 15
PK - Pakistan 15
VE - Venezuela 15
MY - Malesia 14
AU - Australia 11
TH - Thailandia 9
UZ - Uzbekistan 9
CO - Colombia 8
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
DZ - Algeria 6
IE - Irlanda 6
KE - Kenya 6
KZ - Kazakistan 6
SA - Arabia Saudita 6
IL - Israele 5
PH - Filippine 5
PT - Portogallo 5
PY - Paraguay 5
AL - Albania 4
EG - Egitto 4
RO - Romania 4
TW - Taiwan 4
CH - Svizzera 3
CL - Cile 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KH - Cambogia 3
MA - Marocco 3
NG - Nigeria 3
NI - Nicaragua 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
GY - Guiana 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SR - Suriname 2
ZM - Zambia 2
AO - Angola 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MR - Mauritania 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
Totale 5.977
Città #
Singapore 467
Ashburn 394
San Jose 262
Santa Clara 151
Warsaw 150
Chandler 149
Hong Kong 135
Beijing 133
Fairfield 125
Dallas 93
Ho Chi Minh City 81
New York 81
Ann Arbor 78
Los Angeles 67
Hanoi 62
Woodbridge 57
Houston 51
Tokyo 51
Wilmington 48
Jacksonville 45
Council Bluffs 44
Seattle 43
São Paulo 36
Munich 35
Izmir 32
Ferrara 30
Lauterbourg 29
Shanghai 29
Buffalo 27
The Dalles 27
Jakarta 26
Cambridge 25
Addison 23
Helsinki 23
Nanjing 22
Montreal 21
Princeton 21
London 20
Milan 20
Mexico City 18
Orem 18
Phoenix 18
Rome 17
Boardman 16
Brooklyn 16
Brussels 16
Frankfurt am Main 15
Johannesburg 15
Dearborn 14
Atlanta 13
Chicago 13
Poplar 13
Rio de Janeiro 13
San Diego 13
Toronto 13
Columbus 12
Falls Church 12
Chennai 11
Da Nang 11
Nuremberg 11
Belo Horizonte 10
Denver 10
Redwood City 10
Amsterdam 9
Augusta 9
Bologna 9
Chengdu 9
Haiphong 9
Moscow 9
Sydney 9
Boston 8
Brasília 8
Bremen 8
Buriram 8
Guayaquil 8
Hefei 8
Nanchang 8
Ottawa 8
San Mateo 8
Stockholm 8
Tashkent 8
Wuhan 8
Baghdad 7
Ferrara di Monte Baldo 7
Hamburg 7
Manchester 7
Buenos Aires 6
Chongqing 6
Falkenstein 6
Kuala Lumpur 6
Leawood 6
Monmouth Junction 6
Mountain View 6
Porto Alegre 6
Shenyang 6
Washington 6
Ardabil 5
Blumenau 5
Charlotte 5
City of London 5
Totale 3.808
Nome #
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 289
The impact of FDG and amyloid PET-CT in a clinical setting consisting of patients with suspected dementia: the Ferrara experience 240
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 236
Comparison of 18F-FDG vs "early phase" 18F-Florbetapir brain distribution in patients with suspected or known neurodegenerative disease 233
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 233
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 227
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 217
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 207
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 198
Impact of (18)F-Fluoro-Methyl-Choline (FMC) PET/CT in the detection of recurrent prostate cancer: correlation with PSA kinetics and Radiological Imaging. 198
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 191
Technical aspects related to different reconstruction algorithms in FDG PET-CT imaging: a correlation study between SUVmax and volume in neoplastic lesions 186
Lymphoscintigraphy (LS) of Oral Cavity Cancer (OCC) as tool for surgical customization for a selective and modified lymphadenectomy: preliminary report 183
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 182
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 181
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 172
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 166
Dosimetry for treatment with radiolabelled somatostatin analogues. A review 166
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 158
The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in suspected recovery of breast cancer disease: comparison with Radiological Imaging and impact on patient management 157
Erratum: Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: The role of associated risk factors 155
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 149
Lymphoscintigraphy and radio-guided neck dissection in oral cavity squamous cell carcinoma 147
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 145
Radioembolisation with 90Y-microspheres: Dosimetric and radiobiological investigation for multi-cycle treatment 145
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 139
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 137
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 136
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 133
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 128
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 124
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 116
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 110
Clinical platforms in NET patients treated with radioligand therapy: a dosimetric comparison 110
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 102
Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy 59
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study 8
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms 6
Totale 6.069
Categoria #
all - tutte 26.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 55 31
2021/2022254 13 16 20 25 19 13 12 19 7 26 12 72
2022/2023333 29 44 9 46 42 37 13 33 37 6 30 7
2023/2024278 16 25 22 10 24 47 7 40 5 15 14 53
2024/20251.225 44 37 98 66 166 107 74 52 218 110 144 109
2025/20262.952 293 124 260 361 486 208 374 184 290 299 73 0
Totale 6.069